Furthermore, various disease mechanisms, including fibrosis-related mechanisms (i.e., wound healing signaling pathway, hepatic fibrosis signaling pathway, collagen biosynthesis, and enzyme modification), as well as inflammation pathways (i.e., Il-6 signaling, Il-17 signaling), showed a gradual increase with the addition of IOX2 in a concentration-dependent manner. Here, IL17A is linked to Hepatic fibrosis.